Cystitis prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(22 intermediate revisions by 4 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Cystitis}}
{{Cystitis}}
Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]] to learn about editing.
{{CMG}} {{AE}} {{YD}}
==Overview==
Preventative measures to avoid cystitis include abstinence from sexual activity, voiding after intercourse, use of barrier contraception during sexual intercourse, increasing fluid intake and frequency of urination, and use of [[estrogen]] (among post-menopausal women). Single-dose prophylactic antimicrobial therapy prior to sexual intercourse may be administered to patients who have recurrent episodes of cystitis that are associated with sexual activity.


{{CMG}}; {{SCC}}
==Primary Prevention==
==Prevention==
The following preventative measures may reduce the risk of cystitis:
Keeping the genital area clean and remembering to wipe from front to back may reduce the chance of introducing bacteria from the rectal area to the urethra.
<ref name="Raz-1993">{{Cite journal  | last1 = Raz | first1 = R. | last2 = Stamm | first2 = WE. | title = A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. | journal = N Engl J Med | volume = 329 | issue = 11 | pages = 753-6 | month = Sep | year = 1993 | doi = 10.1056/NEJM199309093291102 | PMID = 8350884 }}</ref>
*Abstinence from sexual activity
*Voiding after every intercourse
*Use barrier contraception and avoiding spermicides
*Increasing the intake of fluids and the frequency of urination
*Use of topical estrogen among post-menopausal women


Increasing the intake of fluids may allow frequent urination to flush the bacteria from the bladder. Urinating immediately after sexual intercourse may help eliminate any bacteria that may have been introduced during intercourse. Refraining from urinating for long periods of time may allow bacteria time to multiply, so frequent urinating may reduce risk of cystitis in those who are prone to urinary tract infections.
The use of cranberry to prevent cystitis remains controversial. Cranberry is thought to prevent the adherence of uropathogens to urothelial cells, but its benefit is yet to be proven.<ref>{{Cite journal  |last1 = Hooton | first1 = TM. | title = Clinical practice. Uncomplicated urinary tract infection. | journal = N Engl J Med | volume = 366 | issue = 11 | pages = 1028-37 | month = Mar | year = 2012 |doi = 10.1056/NEJMcp1104429 | PMID = 22417256 }}</ref>
 
Drinking cranberry juice prevents certain types of bacteria from attaching to the wall of the bladder and may lessen the chance of infection.  <ref>[http://nutrition.about.com/od/dietsformedicaldisorders/f/cranberryjuice.htm Nutrition About.com]</ref>
Cranberry extract tablets have also been found to be effective in preventing cystitis, and avoid the taste of cranberry juice, which some find unpleasant.<ref name="Hooton-2012">{{Cite journal  | last1 = Hooton | first1 = TM. | title = Clinical practice. Uncomplicated urinary tract infection. | journal = N Engl J Med | volume = 366 | issue = 11 | pages = 1028-37 | month = Mar | year = 2012 | doi = 10.1056/NEJMcp1104429 | PMID = 22417256 }}</ref>
 
 
 
Recommend abstinence or reduction in frequency of intercourse Sexual intercourse is the strongest risk factor for uncomplicated UTIs;
often this behavioral strategy is not feasible
If spermicides are used, recommend changing to another method
for contraception or prevention of infection
Spermicide use, including use of spermicide-coated condoms, is a
strong risk factor, especially if used with a diaphragm; spermicides
alter the vaginal flora and favor the colonization of uropathogens
Recommend that patient urinate soon after intercourse, drink
fluids liberally, not routinely delay urination, wipe front to
back after defecation, avoid tight-fitting underwear, avoid
douching
In case–control studies, none of these strategies have been shown
to be associated with a reduced risk of recurrent UTIs, and none
have been studied prospectively; however, it is reasonable to
suggest them to the patient, since they pose a low risk and might
be effective
Biologic mediators
Cranberry juice, capsules or tablets Biologic plausibility is based on the inhibition of uropathogen adherence
to uroepithelial cells; clinical data supporting a protective
effect have been limited by design flaws40; a recent randomized,
placebo-controlled trial showed no benefit from cranberry juice41
Topical estrogen In some postmenopausal women, topical estrogen normalizes the
vaginal flora and reduces the risk of recurrent UTIs42; oral estrogens
are not effective
Adhesion blockers (D-mannose, available in health-food stores
and online, is occasionally used as preventive therapy)
UTIs caused by E. coli are initiated by adhesion of the bacteria to mannosylated
receptors in the uroepithelium by means of FimH adhesin
located on type 1 pili; theoretically, mannosides could block adhesion;
however, D-mannose has not been evaluated in clinical trials
 
 
Strategy Comments
Self-diagnosis and self-treatment
First-line antimicrobial regimen is prescribed for future use;
patient
is advised to take it at onset of UTI symptoms
This is not a preventive strategy. Women with previously diagnosed cystitis
can accurately self-diagnose subsequent cystitis in more than 85 to 95%
of cases and can successfully treat themselves43; higher patient satisfaction
with this strategy than with traditional visits to provider for UTI
symptoms and less antimicrobial exposure than with continuous antimicrobial
prophylaxis; should be reserved for motivated women with
previous culture-confirmed cystitis who will comply with the treatment
regimen; urine culture should be obtained periodically before treatment
to confirm presence of UTI and drug susceptibilities
Antimicrobial prophylaxis†
Postcoital antimicrobial prophylaxis: single dose of antimicrobial
agent as soon as feasible after intercourse
Nitrofurantoin, 50–100 mg‡
TMP-SMX, 40 mg and 200 mg or 80 mg and 400 mg§
TMP, 100 mg§
Cephalexin, 250 mg‡
In a placebo-controlled trial, the rate of recurrent cystitis with postcoital
TMP-SMX, 40 mg and 200 mg, was 0.3 episodes per patient-year, vs.
3.6 with placebo (a 92% reduction)44; can be used if UTIs are temporally
related to coitus; absence of bacteriuria should first be confirmed by
negative results on urine culture; results in less antimicrobial exposure
than with continuous prophylaxis; fluoroquinolones (e.g., ciprofloxacin,
125 mg) are highly effective but are not recommended§
Continuous antimicrobial prophylaxis: daily bedtime dose
(except fosfomycin; see below)
Nitrofurantoin, 50–100 mg‡
TMP-SMX, 40 mg and 200 mg (3 times weekly is also effective)§
TMP, 100 mg§
Cephalexin, 125–250 mg‡
Fosfomycin, 3-g sachet every 10 days‡45
Randomized, placebo-controlled trials have shown a reduction in cystitis
recurrences of approximately 95%; side effects are common (e.g., rash,
yeast vaginitis); absence of bacteriuria should first be confirmed by negative
results on urine culture; a 6-month trial is recommended, then treatment
is discontinued and the patient observed; about 50% of patients
have a reversion to the previous pattern of recurrences of cystitis24; if recurrences
continue, prophylaxis may be restarted; rare toxic effects of
long-term exposure to nitrofurantoin include pulmonary hypersensitivity,
chronic hepatitis, and peripheral neuropathy; fluoroquinolones (e.g.,
ciprofloxacin, 125 mg) are highly effective but not recommended§; antimicrobial
resistance in colonizing strains or breakthrough infections are
reported in some studies


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
[[Category:Needs content]]
 
[[Category:Disease]]
[[Category:Inflammations]]
[[Category:Renal Disease]]
[[Category:Nephrology]]
[[Category:Infectious disease]]
[[Category:Primary care]]
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Latest revision as of 13:43, 16 January 2017

Urinary Tract Infections Main Page

Cystitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cystitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultarsound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Tests

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cystitis prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cystitis prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cystitis prevention

CDC on Cystitis prevention

Cystitis prevention in the news

Blogs on Cystitis prevention

Directions to Hospitals Treating Cystitis

Risk calculators and risk factors for Cystitis prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.

Overview

Preventative measures to avoid cystitis include abstinence from sexual activity, voiding after intercourse, use of barrier contraception during sexual intercourse, increasing fluid intake and frequency of urination, and use of estrogen (among post-menopausal women). Single-dose prophylactic antimicrobial therapy prior to sexual intercourse may be administered to patients who have recurrent episodes of cystitis that are associated with sexual activity.

Primary Prevention

The following preventative measures may reduce the risk of cystitis: [1]

  • Abstinence from sexual activity
  • Voiding after every intercourse
  • Use barrier contraception and avoiding spermicides
  • Increasing the intake of fluids and the frequency of urination
  • Use of topical estrogen among post-menopausal women

The use of cranberry to prevent cystitis remains controversial. Cranberry is thought to prevent the adherence of uropathogens to urothelial cells, but its benefit is yet to be proven.[2]

References

  1. Raz, R.; Stamm, WE. (1993). "A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections". N Engl J Med. 329 (11): 753–6. doi:10.1056/NEJM199309093291102. PMID 8350884. Unknown parameter |month= ignored (help)
  2. Hooton, TM. (2012). "Clinical practice. Uncomplicated urinary tract infection". N Engl J Med. 366 (11): 1028–37. doi:10.1056/NEJMcp1104429. PMID 22417256. Unknown parameter |month= ignored (help)


Template:WikiDoc Sources